Showing results (31-40 of 379) with videos related to
Sort By:
Pageof 38
Expert Opinion on Drug Metabolism & Toxicology|January 8, 2022
Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodiesKonstantinos Papamichael, Adam S CheifetzCurrent Opinion in Gastroenterology|April 12, 2019
Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?Konstantinos Papamichael, Adam S CheifetzWorld Journal of Gastroenterology|October 5, 2017
Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapyKonstantinos Papamichael, Adam S CheifetzFrontline Gastroenterology|August 26, 2017
Use of anti-TNF drug levels to optimise patient managementKonstantinos Papamichael, Adam S CheifetzClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2020
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel DiseasesKonstantinos Papamichael, William T Clarke, Niels Vande Casteele, et al.Current Treatment Options in Gastroenterology|May 26, 2005
Infliximab: Use in Inflammatory Bowel DiseaseWin J Travassos, Adam S CheifetzExpert Review of Gastroenterology & Hepatology|August 14, 2009
Management of acute severe ulcerative colitisGlen A Doherty, Adam S CheifetzGastroenterology & Hepatology|September 1, 2018
The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel DiseaseSteven C Lin, Adam S CheifetzJournal of Clinical Gastroenterology|August 31, 2006
Capsule endoscopy retention: is it a complication?Adam S Cheifetz, Blair S LewisDrugs in Context|May 9, 2019
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenanceKartikeya Tripathi, Joseph D FeuersteinPageof 38